> Skip repeated content

Expert Insight: Detecting Pulmonary Arterial Hypertension in Patients With Systemic Sclerosis

Rheumatology Advisor—May 18, 2018

Rheumatology Advisor interviewed HSS rheumatologist Robert F. Spiera, MD, about risk factors and treatment strategies for pulmonary arterial hypertension (PAH) in patients with systemic sclerosis (SSc).

"PAH is an important complication of SSc, and one of the leading causes of mortality in this disease. Although it occurs in a minority of patients, clinicians must be attentive to it, as it can emerge at any point over the course of the disease," Dr. Spiera explained.

In terms of screening, Dr. Spiera noted that "a good history and physical are important at each visit".

"Treatment of SSc-associated PAH uses the same strategies as those used for idiopathic PAH, including vasodilators, endothelin receptor antagonists, prostacyclins, and in many patients, combination therapy," added Dr. Spiera.

Read the full article at rheumatologyadvisor.com
 

 

Need Help Finding a Physician?

Call us toll-free at:
+1.877.606.1555

Conditions & Treatments

adult child
Select A Body Part
Conditions: Adult head Conditions: Adult spine Conditions: Adult shoulder Conditions: Adult elbow Conditions: Adult hand Conditions: Adult hip Conditions: Adult knee Conditions: Adult ankle Conditions: Adult head Conditions: Adult full body Conditions: Child spine Conditions: Child elbow Conditions: Child hip Conditions: Child hand Conditions: Child knee Conditions: Child ankle Conditions: Child full body


Conditions A-Z
A B C D E F G H I
J K L M N O P Q R
S T U V W X Y Z
SEE ALL

Media Contacts

Tracy Hickenbottom
Monique Irons
Sherry Randolph

212.606.1197
mediarelations@hss.edu

Social Media Contacts